These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15549774)

  • 1. Development of CD1d-restricted NKT cells in the mouse thymus.
    Dao T; Guo D; Ploss A; Stolzer A; Saylor C; Boursalian TE; Im JS; Sant'Angelo DB
    Eur J Immunol; 2004 Dec; 34(12):3542-52. PubMed ID: 15549774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.
    Eberl G; Lowin-Kropf B; MacDonald HR
    J Immunol; 1999 Oct; 163(8):4091-4. PubMed ID: 10510341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
    Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
    J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus.
    Dashtsoodol N; Watarai H; Sakata S; Taniguchi M
    PLoS One; 2008; 3(11):e3688. PubMed ID: 18997862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.
    Utting O; Teh SJ; Teh HS
    J Immunol; 1998 Jun; 160(11):5410-9. PubMed ID: 9605142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple constraints at the level of TCRalpha rearrangement impact Valpha14i NKT cell development.
    Hager E; Hawwari A; Matsuda JL; Krangel MS; Gapin L
    J Immunol; 2007 Aug; 179(4):2228-34. PubMed ID: 17675483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex.
    Sandberg JK; Ljunggren HG
    Trends Immunol; 2005 Jul; 26(7):347-9. PubMed ID: 15925541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.
    Wei DG; Lee H; Park SH; Beaudoin L; Teyton L; Lehuen A; Bendelac A
    J Exp Med; 2005 Jul; 202(2):239-48. PubMed ID: 16027237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
    Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
    Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells.
    Elewaut D; Lawton AP; Nagarajan NA; Maverakis E; Khurana A; Honing S; Benedict CA; Sercarz E; Bakke O; Kronenberg M; Prigozy TI
    J Exp Med; 2003 Oct; 198(8):1133-46. PubMed ID: 14557411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.